Sanofi reported 22.34 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
AbbVie 23.45 0.51 Sep/2026
Aena 18.51 0.62 Jun/2026
Alcon AG 42.44 6.03 Jun/2026
Almirall 79.43 0.3 Dec/2025
Amarin 91.05 88.3 Jun/2023
Amgen 18.6 0.53 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Bayer 4.61 0.47 Sep/2026
Biogen 29.15 5.92 Sep/2026
BMW 6.02 0.54 Jun/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
Eli Lilly 64.5 31.61 Sep/2026
Essilor 61.39 7.22 Jun/2026
Fresenius 11.44 4.91 Jun/2026
Fresenius Medical Care 8.23 3.9 Sep/2026
Genmab 16.04 1.05 Jun/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
GRIFOLS 13.04 1.66 Sep/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
J&J 25.86 3.57 Sep/2026
Lakefront Biotherapeutics 2.68 0.14 Jun/2026
Lonza 34.34 2.58 Dec/2025
Mercedes-Benz AG 7.87 0.71 Jun/2026
Merck 17.21 4.47 Jun/2026
Merck 34.36 2.11 Sep/2026
Novartis 19.17 3.24 Sep/2026
Novo Nordisk 10.17 2.61 Jun/2026
Orion 17.23 1.3 Jun/2026
Pfizer 15.2 3.72 Sep/2026
Philips 23.76 9.44 Jun/2026
Recordati 22.75 5.09 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 22.34 3.38 Sep/2026
Sanofi 21.74 11.35 Sep/2026
SAP 21.47 2.61 Jun/2026
UCB 29.7 5.52 Dec/2025
Vinci 14.45 0.45 Jun/2026
Volkswagen 3.02 2.12 Mar/2026